Receptor block chemical strucrure pharmacokinetic effect Švestka, 2001 Anxiety therapy -neurobiological basis
• GABA-A RECEPTORCOMPLEX (omega 1-6) -benzodiazepine-agonists decrease anxiety • SEROTONERGIC SYSTEM (dorsal raphe nucleus)
-5-HT antagonists decrease anxiety • NORADRENERGIC SYSTEM (locus coruleus) -autoreceptor stimulants (clonidin) decrease anxiety, presynaptic alfa2 inhibitor yohimbin panic provoking, postsynaptic béta blockers effect • Dopaminergic system's role is also likely General principles of therapy 
ANTIDEPRESSIVES -SSRI
• fluoxetine (Prozac, stb) • fluvoxamine (Fevarin) • paroxetin (Seroxat) • citalopram (Seropram) • sertraline (Zoloft) serotonergic reuptake increase: • tianeptine (Coaxil) OTHER ANTIDEPRESSIVES Addiction -therapy
• (1)detoxification, involving medications and supportive measures to minimize effects of the drug and of its withdrawal; • (2) substitution therapy with related drugs, which may be temporary (as in withdrawal of sedatives) • (3) deterrents to further ingestion of alcohol (e.g., disulfiram) • (4) antianxiety or antidepressant medication; • (5) group and individual psychotherapies intended to alter neurotic characteristiscs that promote psychological dependence.
• Treatment of alcohol dependence begins with detoxification aimed at normalization of metabolic processes and prevention of withdrawal delirium and seizures. correction of electrolyte imbalance; treatment of infection; and (usually) administration of intravenous fluids with glucose. These therapies should continue until the medical condition has normalized.
Management of alcohol withdrawal syndromes 1. Thiamine; folic acid 2. Phenytoin or carbamazepine, in patients with a history of withdrawal seizures 3. Haloperidol: 2-5 mg bid for patients with alcoholic hallucinosis 4. For delirium tremens: -Iv. im. per os diazepam 10 mg (or lorazepam 2-4 mg), followed by 5-mg doses every 5 minutes until calm. Once the patient is stabilized, the dose may be tapered slowly over 4 or 5 days -Seclusion and restraints as necessary -Adequate hydration and nutrition
Considerations for the therapy
• Antipsychotic medications can help reduce psychotic symptoms (e.g., hallucinations) or escalating anxiety or agitation.
• Benzodiazepines and alpha2-adrenergic agonists (e.g., clonidine) can help reduce excessive autonomic hyperactivity (e.g., elevated blood pressure, elevated pulse).
• Beta-blockers (e.g., propranolol) can help reduce excessive autonomic hyperactivity and somatic anxiety
• For persons experiencing withdrawal seizures, an antiepileptic medication (e.g., phenytoin, carbamazepine) is often used prophylactically if seizure activity continues After detoxification, recommendations include one of the following:
• Continued treatment on an outpatient basis.
• Continued somatic and/or psychosocial treatment in a 21-to 28-day inpatient treatment program (helpful for patients who fail to stop drinking after repeated attempts at detoxification), possibly followed by a 6-to 24-month program in a long-term treatment facility.
